Biotech · Private company
Gan and Lee Pharmaceuticals, USA
Track this companyFree. Adds Gan and Lee Pharmaceuticals, USA to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Gan & Lee Insulin Glargine InjectionPhase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- Gan & Lee Insulin Glargine InjectionPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Gan & Lee Insulin Lispro InjectionPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- HumalogPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Lantus®Phase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Lantus®Phase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- GLR2007Phase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- GZR18Phase 2 · Obesity and OverweightClinicalTrials.gov · fetched Nov 12, 2026
- TirzepatidePhase 2 · Obesity and OverweightClinicalTrials.gov · fetched Nov 12, 2026
- GZR-18Phase 1 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight ParticipantsPHASE2 · COMPLETED · started Feb 24, 2025ClinicalTrials.gov NCT06737042 · fetched Nov 12, 2026
- Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy SubjectsPHASE1 · COMPLETED · started Mar 8, 2022ClinicalTrials.gov NCT05328726 · fetched Nov 12, 2026
- Evaluation of GLR2007 for Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04444427 · fetched Nov 12, 2026
- Gan & Lee Evaluation of New Biosimilar for Type 1 LisproPHASE3 · WITHDRAWN · started Dec 4, 2019ClinicalTrials.gov NCT04254380 · fetched Nov 12, 2026
- Gan & Lee Insulin Glargine Target Type (1) Evaluating ResearchPHASE3 · COMPLETED · started Oct 31, 2017ClinicalTrials.gov NCT03371082 · fetched Nov 12, 2026
- Gan & Lee Insulin Glargine Target Type (2) Evaluating ResearchPHASE3 · COMPLETED · started Oct 31, 2017ClinicalTrials.gov NCT03371108 · fetched Nov 12, 2026